Japan drug approvals

top of page

iPharmaCenter

News | Blogs | Healthcare | Consulting

Contact: info@ipharmacenter.com

Home
Pharma
Healthcare News
Healthcare Policies
Disease News
Conferences
Others
- COVID-19
- Contact

Search

ipharmaservices

Sep 1, 2024

GSK's Nucala Receives Approval in Japan for Treating Adults with Chronic Rhinosinusitis with Nasal Polyps | iPharmaCenter

0

ipharmaservices

Jun 24, 2024

GSK’s Omjjara (Momelotinib) Receives Approval in Japan for Myelofibrosis Treatment | 2024 | iPharmaCenter

0

Japan Drug Approvals | March 2024 | PMDA | MHLW Updates | iPharmaCenter

ipharmaservices

Mar 28, 2024

Japan Drug Approvals | March 2024 | PMDA | MHLW Updates | iPharmaCenter

0

Drug approvals in Japan | PMDA | MHLW Approvals | 2022 | News | Media | Japan | iPharmaCenter

ipharmaservices

Dec 24, 2022

Drug approvals in Japan | PMDA | MHLW Approvals | 2022 | News | Media | Japan | iPharmaCenter

0

Novartis and BeiGene collaboration strengthens the Swiss drugmaker's oncology portfolio

ipharmaservices

Jan 12, 2021

Novartis and BeiGene collaboration strengthens the Swiss drugmaker's oncology portfolio

0

ipharmaservices

Sep 26, 2020

Gilead received the approval of Jyseleca from the European and Japan regulatory authorities for RA

0

AZ received one more approval in Japan, received approval of Imfinzi for SCLC

ipharmaservices

Aug 22, 2020

AZ received one more approval in Japan, received approval of Imfinzi for SCLC

0

JAPAN HEALTHCARE SYSTEM

ipharmaservices

Aug 17, 2020

JAPAN HEALTHCARE SYSTEM

0

ipharmaservices

Jul 9, 2020

Eisai's Dayvigo was approved in Japan and Hong Kong for insomnia

0

AstraZeneca's Lokelma approved in Japan

ipharmaservices

Mar 29, 2020

AstraZeneca's Lokelma approved in Japan

0

For sponsored articles, link insertions, and advertisements, please write to info@ipharmacenter.com

Find the latest pharma and healthcare news on Telegram now. Simply scan the QR code.

Rephrase with Ginger (Cmd+⌥+E)

iPharmaCenter Telegran_edited.jpg

bottom of page